nach oben

Lasers in Medical Science

Erschienen in:

29.11.2018 | Original Article

Essential Role of mTOR Signaling in Human Retinal Pigment Epithelial Cell Regeneration After Laser Photocoagulation

verfasst von: Sanjar Batirovich Madrakhimov, Jin Young Yang, Ha Yan Park, Tae Kwann Park

Erschienen in: Lasers in Medical Science | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

This study assessed the role of mechanistic target of rapamycin (mTOR) pathway in the human adult retinal pigment epithelial (ARPE) cell response after laser photocoagulation (LP). The effect of mTOR inhibition on ARPE-19 cell was investigated by rapamycin treatment after LP. Cell viability and proliferation were explored using MTT and EdU assays, respectively. The expression of mTOR-related proteins and epithelial-mesenchymal transition (EMT) markers was verified by Western blot. Rapamycin retarded the LP area recovery in a dose-dependent manner by the 120 h, while LP+DMSO vehicle-treated cells completely restored the lesion zone (P ≤ 0.01). ARPE-19 cell viability is significantly lower in LP + rapamycin 80 and 160 ng/ml treated cultures compared to LP control at 120 h (P ≤ 0.001). LP control group demonstrated significantly more proliferative cells compared to untreated cells at the 72 and 120 h, whereas EdU-positive cell numbers in cultures treated with rapamycin at concentrations of 80 and 160 ng/ml were similar to baseline values (P ≤ 0.01). mTOR pathway activation is essential for regulation of the RPE cell migration and proliferation after LP. mTOR inhibition with rapamycin effectively blocks the migration and proliferation of the RPE cells. Our results demonstrate that mTOR has an important role in ARPE-19 cell as a regulator of cell behavior under stress conditions, suggesting that mTOR could be a promising therapeutic target for numerous retinal diseases.

Diabetic Retinopathy Study Research Group (1978) Photocoagulation treatment of proliferative diabetic retinopathy: The second report of diabetic retinopathy study findings. Ophthalmology 85:82–106. https://doi.org/10.1016/S0161-6420(78)35693-1 CrossRef

Early Treatment Diabetic Retinopathy Study research group (1987) Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 2. Ophthalmology 94:761–774CrossRef

Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group (2004) Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 102:233–248 discussion 248–50PubMedPubMedCentral

Priebe LA, Cain CP, Welch AJ (1975) Temperature rise required for production of minimal lesions in the Macaca mulatta retina. Am J Ophthalmol 79:405–413. https://doi.org/10.1016/0002-9394(75)90613-3 CrossRefPubMed

Tababat-Khani P, Berglund LM, Agardh CD, Gomez MF, Agardh E (2013) Photocoagulation of human retinal pigment epithelial cells in vitro: evaluation of necrosis, apoptosis, cell migration, cell proliferation and expression of tissue repairing and cytoprotective genes. PLoS One 8(8):e70465. https://doi.org/10.1371/journal.pone.0070465 CrossRefPubMedPubMedCentral

Campochiaro PA (2000) Retinal and choroidal neovascularization. J Cell Physiol 184:301–310. https://doi.org/10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H CrossRefPubMed

Duh EJ, Yang HS, Haller JA, De Juan E, Humayun MS, Gehlbach P, Melia M et al (2004) Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol 137(4):668–674. https://doi.org/10.1016/j.ajo.2003.11.015 CrossRefPubMed

Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85(3):845–881. https://doi.org/10.1152/physrev.00021.2004 CrossRefPubMed

Sparrrow JR, Hicks D, Hamel CP (2010) The retinal pigment epithelium in health and disease. Curr Mol Med 10(9):802–823. https://doi.org/10.2174/156652410793937813 CrossRef

10.

Muether PS, Neuhann I, Buhl C, Hermann MM, Kirchhof B, Fauser S (2013) Intraocular growth factors and cytokines in patients with dry and neovascular age-related macular degeneration. Retina 33(9):1809–1814. https://doi.org/10.1097/IAE.0b013e318285cd9e CrossRefPubMed

11.

Kernt M, Neubauer AS, Liegl RG, Hirneiss C, Alge CS, Wolf A, Ulbig MW, Kampik A (2010) Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF. Br J Ophthalmol 94(11):1533–1539. https://doi.org/10.1136/bjo.2010.182162 CrossRefPubMed

12.

Hattenbach LO, Beck KF, Pfeilschifter J, Koch F, Ohrloff C, Schacke W (2005) Pigment-epithelium-derived factor is upregulated in photocoagulated human retinal pigment epithelial cells. Ophthalmic Res 37(6):341–346. https://doi.org/10.1159/000088263 CrossRefPubMed

13.

Polivka J Jr, Janku F (2014) Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther 142(2):164–175. https://doi.org/10.1016/j.pharmthera.2013.12.004 CrossRefPubMed

14.

Kim YC, Guan KL (2015) mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 125(1):25–32. https://doi.org/10.1172/JCI73939 CrossRefPubMedPubMedCentral

15.

Perl A (2015) mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging. Ann N Y Acad Sci 1346(1):33–44. https://doi.org/10.1111/nyas.12756 CrossRefPubMedPubMedCentral

16.

Johnson SC, Rabinovitch PS, Kaeberlein M (2013) mTOR is a key modulator of ageing and age-related disease. Nature 493(7432):338–345. https://doi.org/10.1038/nature11861 CrossRefPubMedPubMedCentral

17.

Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149(2):274–293. https://doi.org/10.1016/j.cell.2012.03.017 CrossRefPubMedPubMedCentral

18.

Jing L, Sang GK, Blenis J (2014) Rapamycin: one drug, many effects. Cell Metab 19(3):373–379. https://doi.org/10.1016/j.cmet.2014.01.001 CrossRef

19.

Zhao C, Vollrath D (2011) mTOR pathway activation in age-related retinal disease. Aging (Albany NY) 3(4):346–347. https://doi.org/10.18632/aging.100303 CrossRef

20.

Jacot JL, Sherris D (2011) Potential therapeutic roles for inhibition of the PI3K/Akt/mTOR pathway in the pathophysiology of diabetic retinopathy. J Ophthalmol 2011:589813PubMedPubMedCentral

21.

Yagasaki R, Nakahara T, Ushikubo H, Mori A, Sakamoto K, Ishii K (2014) Anti-angiogenic effects of mammalian target of rapamycin inhibitors in a mouse model of oxygen-induced retinopathy. Biol Pharm Bull 37(11):1838–1842. https://doi.org/10.1248/bpb.b14-00487 CrossRefPubMed

22.

Çakmak H, Ergin K, Bozkurt G, Kocatürk T, Evliçoğlu GE (2016) The effects of topical everolimus and sunitinib on corneal neovascularization. Cutan Ocul Toxicol 35(2):97–103PubMed

23.

Faghiri Z, Bazan NG (2010) PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis. Exp Eye Res 90(6):718–725 https://doi.org/10.1016/j.exer.2010.03.002 CrossRefPubMedPubMedCentral

24.

Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM (1996) ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62:155–169. https://doi.org/10.1006/exer.1996.0020 CrossRefPubMed

25.

Hamel CP, Tsilou E, Pfeffer BA, Hooks JJ, Detrick B, Redmond TM (1993) Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro. J Biol Chem 268:15751–15757PubMed

26.

Finnemann SC, Bonilha VL, Marmorstein AD, RodriguezBoulan E (1997) Phagocytosis of rod outer segments by retinal pigment epithelial cells requires alpha(v)beta5 integrin for binding but not for internalization. Proc Natl Acad Sci U S A 94:12932–12937. https://doi.org/10.1073/pnas.94.24.12932 CrossRefPubMedPubMedCentral

27.

Park TK, Lee SH, Choi JS, Nah SK, Kim HJ, Park HY, Lee H, Lee SHS, Park K (2017) Adeno-associated viral vector-mediated mTOR inhibition by short hairpin RNA suppresses laser-induced choroidal neovascularization. Mol Ther Nucleic Acids 8:26–35. https://doi.org/10.1016/j.omtn.2017.05.012 CrossRefPubMedPubMedCentral

28.

Oh JR, Han JW, Kim YK, Ohn YH, Park TK (2017) The effects of anti-vascular endothelial growth factor agents on human retinal pigment epithelial cells under high glucose conditions. Int J Ophthalmol 10(2):203–210PubMedPubMedCentral

29.

Zong H, Yin B, Zhou H, Cai D, Ma B, Xiang Y (2014) Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition. Mol Biol Rep 41(7):4507–4512. https://doi.org/10.1007/s11033-014-3321-4 CrossRefPubMed

30.

Han B, Cui H, Kang L, Zhang X, Jin Z, Lu L, Fan Z (2015) Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway. Tumour Biol 36(8):6295–6304. https://doi.org/10.1007/s13277-015-3315-4 CrossRefPubMed

31.

Liegl R, Koenig S, Siedlecki J, Haritoglou C, Kampik A, Kernt M (2014) Temsirolimus inhibits proliferation and migration in retinal pigment epithelial and endothelial cells via mTOR inhibition and decreases VEGF and PDGF expression. PLoS One 9(2):e88203. https://doi.org/10.1371/journal.pone.0088203 CrossRefPubMedPubMedCentral

32.

Briggs MW, Sacks DB (2003) IQGAP proteins are integral components of cytoskeletal regulation. EMBO Rep 4(6):571–574. https://doi.org/10.1038/sj.embor.embor867 CrossRefPubMedPubMedCentral

33.

Noritake J, Watanabe T, Sato K, Wang S, Kaibuchi K (2005) IQGAP1: a key regulator of adhesion and migration. J Cell Sci 118(Pt 10):2085–2092. https://doi.org/10.1242/jcs.02379 CrossRefPubMed

34.

Wang JB, Sonn R, Tekletsadik YK, Samorodnitsky D, Osman MA (2009) IQGAP1 regulates cell proliferation through a novel CDC42-mTOR pathway. J Cell Sci 122(Pt 12):2024–2033. https://doi.org/10.1242/jcs.044644 CrossRefPubMedPubMedCentral

35.

McCrea PD, Maher MT, Gottardi CJ (2015) Nuclear signaling from cadherin adhesion complexes. Curr Top Dev Biol 112:129–196. https://doi.org/10.1016/bs.ctdb.2014.11.018 CrossRefPubMedPubMedCentral

36.

Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420–1428. https://doi.org/10.1172/JCI39104 CrossRefPubMedPubMedCentral

37.

McKay BS, Irving PE, Skumatz CM, Burke JM (1997) Cell-cell adhesion molecules and the development of an epithelial phenotype in cultured human retinal pigment epithelial cells. Exp Eye Res 65(5):661–671. https://doi.org/10.1006/exer.1997.0374 CrossRefPubMed

38.

Youn YH, Hong J, Burke JM (2006) Cell phenotype in normal epithelial cell lines with high endogenous N-cadherin: comparison of RPE to an MDCK subclone. Invest Ophthalmol Vis Sci 47(6):2675–2685. https://doi.org/10.1167/iovs.05-1335 CrossRefPubMed

39.

Liu NN, Zhao N, Cai N (2015) Suppression of the proliferation of hypoxia-induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling. IUBMB Life 67(6):446–452. https://doi.org/10.1002/iub.1382 CrossRefPubMed

40.

Copp J, Manning G, Hunter T (2009) TORC-specific phosphorylation of mTOR: phospho-Ser2481 is a marker for intact mTOR-C2. Cancer Res 69(5):1821–1827. https://doi.org/10.1158/0008-5472.CAN-08-3014 CrossRefPubMedPubMedCentral

41.

Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, Markhard AL, Sabatini DM (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22(2):159–168. https://doi.org/10.1016/j.molcel.2006.03.029 CrossRefPubMed

42.

Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J, Mueller M, Fumagalli S, Kozma SC, Thomas G (2004) S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 24(8):3112–3124. https://doi.org/10.1128/MCB.24.8.3112-3124.2004 CrossRefPubMedPubMedCentral

43.

Butler DE, Marlein C, Walker HF et al (2017) Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer. Oncotarget 8(34):56698–56713. https://doi.org/10.18632/oncotarget.18082 CrossRefPubMedPubMedCentral

44.

Nguyen QD, Merrill PT, Clark WL, Banker AS, Fardeau C, Franco P, LeHoang P, Ohno S et al (2016) Intravitreal Sirolimus for noninfectious uveitis: a phase III Sirolimus study Assessing double-masKed Uveitis TReAtment (SAKURA). Ophthalmology 123(11):2413–2423. https://doi.org/10.1016/j.ophtha.2016.07.029 CrossRefPubMed

Titel: Essential Role of mTOR Signaling in Human Retinal Pigment Epithelial Cell Regeneration After Laser Photocoagulation
verfasst von: Sanjar Batirovich Madrakhimov
Jin Young Yang
Ha Yan Park
Tae Kwann Park
Publikationsdatum: 29.11.2018
Verlag: Springer London
Erschienen in: Lasers in Medical Science / Ausgabe 5/2019
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-018-2692-5

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

The antifungal agent of silver nanoparticles activated by diode laser as light source to reduce C. albicans biofilms: an in vitro study

Blue light-emitting diode in healthy vaginal mucosa—a new therapeutic possibility

The effect of low-level laser radiation on improving inferior alveolar nerve damage after sagittal split osteotomy: a systematic review

Effect of lights with various wavelengths on bleaching by 30% hydrogen peroxide

The effects of repeated applications of antimicrobial photodynamic therapy in the treatment of residual periodontal pockets: a systematic review

The effect of low-level laser irradiation on hyperglycemia-induced inflammation in human gingival fibroblasts